one of these These are the most likely bidders. Pfizer, Aventis, Roche, Genentech, Mayne , Cephalon. There are many which means due to supply and demand forces if many different companies can all use your product with theirs , then your product and company is very valuable and the premium will be larger than many believe could be.
genentech inc., page-6
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.78M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.3¢ | 18.0¢ | $109.7K | 609.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 11628739 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 5865798 | 21 |
View Market Depth
| Last trade - 15.10pm 17/09/2024 (20 minute delay) ? |
| SRX (ASX) Chart |